Literature DB >> 23132492

Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections.

Pascale S Guiton1, Thomas J Hannan, Bradley Ford, Michael G Caparon, Scott J Hultgren.   

Abstract

Urinary catheterization elicits major histological and immunological changes that render the bladder susceptible to microbial invasion, colonization, and dissemination. However, it is not understood how catheters induce these changes, how these changes act to promote infection, or whether they may have any protective benefit. In the present study, we examined how catheter-associated inflammation impacts infection by Enterococcus faecalis, a leading cause of catheter-associated urinary tract infection (CAUTI), a source of significant societal and clinical challenges. Using a recently optimized murine model of foreign body-associated UTI, we found that the implanted catheter itself was the primary inducer of inflammation. In the absence of the silicone tubing implant, E. faecalis induced only minimal inflammation and was rapidly cleared from the bladder. The catheter-induced inflammation was only minimally altered by subsequent enterococcal infection and was not suppressed by inhibitors of the neurogenic pathway and only partially by dexamethasone. Despite the robust inflammatory response induced by urinary implantation, E. faecalis produced biofilm and high bladder titers in these animals. Induction of inflammation in the absence of an implanted catheter failed to promote infection, suggesting that the presence of the catheter itself is essential for E. faecalis persistence in the bladder. Immunosuppression prior to urinary catheterization enhanced E. faecalis colonization, suggesting that implant-mediated inflammation contributes to the control of enterococcal infection. Thus, this study underscores the need for novel strategies against CAUTIs that seek to reduce the deleterious effects of implant-mediated inflammation on bladder homeostasis while maintaining an active immune response that effectively limits bacterial invaders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23132492      PMCID: PMC3536162          DOI: 10.1128/IAI.00856-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  99 in total

Review 1.  Glucocorticoid resistance - what is known?

Authors:  Michael Norman; Stephen D Hearing
Journal:  Curr Opin Pharmacol       Date:  2002-12       Impact factor: 5.547

2.  Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media.

Authors:  Wenzhou Hong; Richard A Juneau; Bing Pang; W Edward Swords
Journal:  J Innate Immun       Date:  2009-02-27       Impact factor: 7.349

Review 3.  Developments in anti-asthma glucocorticoids.

Authors:  P T Andersson; C G Persson
Journal:  Agents Actions Suppl       Date:  1988

4.  Study of urinary infections by catheterization.

Authors:  C W Norden
Journal:  N Engl J Med       Date:  1968-04-25       Impact factor: 91.245

Review 5.  Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms.

Authors:  C L Parsons
Journal:  Urol Clin North Am       Date:  1986-11       Impact factor: 2.241

6.  Capsaicin sensitive afferents contribute to acute airway edema following tracheal instillation of hydrochloric acid or gastric juice in the rat.

Authors:  C R Martling; J M Lundberg
Journal:  Anesthesiology       Date:  1988-03       Impact factor: 7.892

7.  Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota.

Authors:  Parameth Thiennimitr; Sebastian E Winter; Maria G Winter; Mariana N Xavier; Vladimir Tolstikov; Douglas L Huseby; Torsten Sterzenbach; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 8.  New insights into the regulation of vascular permeability.

Authors:  Alejandra Chavez; Monica Smith; Dolly Mehta
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

9.  Biochemical characterization of the neutrophil-specific antigen NB1.

Authors:  D F Stroncek; K M Skubitz; J J McCullough
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

10.  Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients.

Authors:  A I Hartstein; S B Garber; T T Ward; S R Jones; V H Morthland
Journal:  Infect Control       Date:  1981 Sep-Oct
View more
  32 in total

Review 1.  Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.

Authors:  Roger D Klein; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2020-02-18       Impact factor: 60.633

2.  EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice.

Authors:  Ana L Flores-Mireles; Jerome S Pinkner; Michael G Caparon; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2014-09-17       Impact factor: 17.956

Review 3.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

Review 4.  The unexplored relationship between urinary tract infections and the autonomic nervous system.

Authors:  Michael E Hibbing; Matt S Conover; Scott J Hultgren
Journal:  Auton Neurosci       Date:  2015-06-06       Impact factor: 3.145

5.  Establishment and Characterization of UTI and CAUTI in a Mouse Model.

Authors:  Matt S Conover; Ana L Flores-Mireles; Michael E Hibbing; Karen Dodson; Scott J Hultgren
Journal:  J Vis Exp       Date:  2015-06-23       Impact factor: 1.355

6.  Bladder catheterization increases susceptibility to infection that can be prevented by prophylactic antibiotic treatment.

Authors:  Matthieu Rousseau; H M Sharon Goh; Sarah Holec; Matthew L Albert; Rohan Bh Williams; Molly A Ingersoll; Kimberly A Kline
Journal:  JCI Insight       Date:  2016-09-22

Review 7.  Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Authors:  Ana Flores-Mireles; Teri N Hreha; David A Hunstad
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

Review 9.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

10.  Enterococcus faecalis Promotes Innate Immune Suppression and Polymicrobial Catheter-Associated Urinary Tract Infection.

Authors:  Brenda Yin Qi Tien; Hwee Mian Sharon Goh; Kelvin Kian Long Chong; Soumili Bhaduri-Tagore; Sarah Holec; Regine Dress; Florent Ginhoux; Molly A Ingersoll; Rohan B H Williams; Kimberly A Kline
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.